Drug Shortage Report for FUNGIZONE
| Report ID | 16534 |
| Drug Identification Number | 00029149 |
| Brand name | FUNGIZONE INTRAVENOUS INJECTION 50MG |
| Common or Proper name | Amphotericin B |
| Company Name | CHEPLAPHARM ARZNEIMITTEL GMBH |
| Market Status | MARKETED |
| Active Ingredient(s) | AMPHOTERICIN B |
| Strength(s) | 50MG |
| Dosage form(s) | POWDER FOR SOLUTION |
| Route of administration | INTRAVENOUS |
| Packaging size | (1 VL) 15 ML |
| ATC code | J02AA |
| ATC description | ANTIMYCOTICS FOR SYSTEMIC USE |
| Reason for shortage | Other (Please describe in comments) |
| Anticipated start date | 2018-05-22 |
| Actual start date | 2018-04-20 |
| Estimated end date | 2019-05-22 |
| Actual end date | 2019-05-22 |
| Shortage status | Resolved |
| Updated date | 2019-05-23 |
| Company comments | Product available |
| Health Canada comments | |
| Tier 3 Status | No |
| Contact Address | ZIEGELHOF 24 GREIFSWALD, MECKLENBURG - WEST POMERANIA GERMANY 17489 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.